Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 11 | 2025 | 472 | 3.710 |
Why?
|
| Appendicitis | 4 | 2022 | 81 | 1.650 |
Why?
|
| Thoracic Injuries | 2 | 2022 | 43 | 1.460 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 41 | 1.250 |
Why?
|
| Herniorrhaphy | 3 | 2025 | 70 | 1.210 |
Why?
|
| Fundoplication | 2 | 2025 | 25 | 0.990 |
Why?
|
| Histamine H2 Antagonists | 1 | 2025 | 15 | 0.950 |
Why?
|
| Hernia, Umbilical | 1 | 2025 | 7 | 0.940 |
Why?
|
| Retrospective Studies | 16 | 2025 | 6595 | 0.930 |
Why?
|
| Proton Pump Inhibitors | 1 | 2025 | 42 | 0.930 |
Why?
|
| Gastroesophageal Reflux | 2 | 2025 | 92 | 0.910 |
Why?
|
| Gift Giving | 1 | 2024 | 8 | 0.900 |
Why?
|
| Postoperative Complications | 4 | 2025 | 1293 | 0.900 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2022 | 61 | 0.880 |
Why?
|
| Internship and Residency | 2 | 2024 | 800 | 0.840 |
Why?
|
| Enteral Nutrition | 1 | 2023 | 54 | 0.830 |
Why?
|
| Hepatoblastoma | 1 | 2023 | 9 | 0.810 |
Why?
|
| Wounds, Gunshot | 1 | 2023 | 56 | 0.800 |
Why?
|
| Rib Fractures | 1 | 2022 | 19 | 0.770 |
Why?
|
| Child | 13 | 2025 | 4520 | 0.760 |
Why?
|
| Interviews as Topic | 1 | 2024 | 509 | 0.760 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 30 | 0.760 |
Why?
|
| Craniocerebral Trauma | 1 | 2022 | 55 | 0.750 |
Why?
|
| Wounds, Penetrating | 1 | 2022 | 26 | 0.750 |
Why?
|
| Musa | 1 | 2021 | 7 | 0.750 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2021 | 8 | 0.750 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 8 | 0.740 |
Why?
|
| Abdominal Injuries | 1 | 2022 | 30 | 0.740 |
Why?
|
| General Surgery | 1 | 2024 | 210 | 0.730 |
Why?
|
| Phytotherapy | 2 | 2018 | 53 | 0.680 |
Why?
|
| Critical Illness | 1 | 2023 | 321 | 0.670 |
Why?
|
| Gastric Bypass | 1 | 2021 | 76 | 0.670 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 59 | 0.670 |
Why?
|
| Infant | 8 | 2025 | 1649 | 0.660 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 297 | 0.650 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 97 | 0.640 |
Why?
|
| Patient Readmission | 1 | 2023 | 430 | 0.620 |
Why?
|
| Plant Extracts | 2 | 2018 | 172 | 0.620 |
Why?
|
| Treatment Outcome | 12 | 2025 | 5625 | 0.620 |
Why?
|
| Appendix | 1 | 2018 | 17 | 0.600 |
Why?
|
| Cell Respiration | 1 | 2018 | 21 | 0.580 |
Why?
|
| Neuroblastoma | 1 | 2018 | 52 | 0.570 |
Why?
|
| Adolescent | 11 | 2025 | 6229 | 0.540 |
Why?
|
| Humans | 26 | 2025 | 63152 | 0.520 |
Why?
|
| Infant, Newborn | 5 | 2025 | 1355 | 0.510 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 663 | 0.510 |
Why?
|
| Ultrasonography | 1 | 2018 | 481 | 0.500 |
Why?
|
| Child, Preschool | 7 | 2025 | 1988 | 0.500 |
Why?
|
| Thoracoscopy | 2 | 2004 | 25 | 0.440 |
Why?
|
| Male | 15 | 2025 | 29717 | 0.420 |
Why?
|
| Appendectomy | 3 | 2020 | 54 | 0.400 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 660 | 0.400 |
Why?
|
| Hemothorax | 2 | 2022 | 7 | 0.380 |
Why?
|
| Female | 16 | 2025 | 32709 | 0.380 |
Why?
|
| Thoracotomy | 2 | 2022 | 46 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 1606 | 0.370 |
Why?
|
| Sutures | 2 | 2016 | 41 | 0.350 |
Why?
|
| Length of Stay | 4 | 2022 | 808 | 0.320 |
Why?
|
| Young Adult | 4 | 2023 | 4673 | 0.300 |
Why?
|
| Laparoscopes | 1 | 2007 | 25 | 0.280 |
Why?
|
| Touch | 1 | 2007 | 27 | 0.270 |
Why?
|
| Rhodiola | 2 | 2018 | 15 | 0.260 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 126 | 0.260 |
Why?
|
| Pandemics | 2 | 2022 | 672 | 0.250 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 23 | 0.240 |
Why?
|
| Geographic Information Systems | 1 | 2005 | 23 | 0.240 |
Why?
|
| Umbilicus | 1 | 2025 | 16 | 0.240 |
Why?
|
| Operative Time | 1 | 2025 | 91 | 0.230 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2022 | 123 | 0.230 |
Why?
|
| Esophagoplasty | 1 | 2004 | 4 | 0.220 |
Why?
|
| Esophageal Atresia | 1 | 2004 | 9 | 0.220 |
Why?
|
| Esophagus | 1 | 2004 | 50 | 0.220 |
Why?
|
| Reoperation | 1 | 2025 | 290 | 0.220 |
Why?
|
| Personnel Selection | 1 | 2024 | 55 | 0.210 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 129 | 0.210 |
Why?
|
| Pain, Postoperative | 1 | 2025 | 162 | 0.210 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2571 | 0.210 |
Why?
|
| Massachusetts | 3 | 2023 | 2073 | 0.200 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 58 | 0.200 |
Why?
|
| Disease-Free Survival | 1 | 2023 | 242 | 0.190 |
Why?
|
| Ligation | 1 | 2022 | 38 | 0.190 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 2451 | 0.190 |
Why?
|
| Pylorus | 1 | 2021 | 10 | 0.190 |
Why?
|
| Laparotomy | 1 | 2022 | 51 | 0.190 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 350 | 0.180 |
Why?
|
| Adult | 5 | 2024 | 16736 | 0.170 |
Why?
|
| Gastrectomy | 1 | 2021 | 40 | 0.170 |
Why?
|
| RNA, Viral | 1 | 2022 | 276 | 0.170 |
Why?
|
| Referral and Consultation | 1 | 2022 | 422 | 0.150 |
Why?
|
| Lung | 1 | 2004 | 952 | 0.150 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 10 | 0.150 |
Why?
|
| Cytotoxins | 1 | 2018 | 12 | 0.150 |
Why?
|
| Random Allocation | 2 | 2016 | 199 | 0.140 |
Why?
|
| Guinea Pigs | 1 | 2016 | 84 | 0.130 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 1092 | 0.130 |
Why?
|
| Suture Techniques | 1 | 2017 | 99 | 0.130 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1461 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2018 | 980 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2673 | 0.130 |
Why?
|
| Cell Survival | 1 | 2018 | 568 | 0.130 |
Why?
|
| Time Factors | 1 | 2023 | 3754 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 417 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 2179 | 0.120 |
Why?
|
| Wound Healing | 1 | 2016 | 189 | 0.120 |
Why?
|
| Pancreas | 1 | 2015 | 150 | 0.120 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2015 | 108 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 81 | 0.110 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.110 |
Why?
|
| Braces | 1 | 2014 | 10 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2015 | 158 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2016 | 1004 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2017 | 725 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 288 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 308 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5429 | 0.090 |
Why?
|
| Animals | 4 | 2016 | 20610 | 0.070 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 14 | 0.070 |
Why?
|
| Jejunal Diseases | 1 | 2007 | 7 | 0.070 |
Why?
|
| Dextrans | 1 | 2007 | 46 | 0.070 |
Why?
|
| Choristoma | 1 | 2007 | 22 | 0.070 |
Why?
|
| Intussusception | 1 | 2007 | 14 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 2007 | 71 | 0.070 |
Why?
|
| Stomach | 1 | 2007 | 86 | 0.070 |
Why?
|
| Spermatic Cord Torsion | 1 | 2006 | 13 | 0.070 |
Why?
|
| Hyaluronic Acid | 1 | 2007 | 67 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2006 | 41 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 2007 | 91 | 0.060 |
Why?
|
| Equipment Design | 1 | 2007 | 345 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 149 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2006 | 564 | 0.060 |
Why?
|
| Aged | 1 | 2021 | 14333 | 0.060 |
Why?
|
| Soft Tissue Infections | 1 | 2005 | 49 | 0.060 |
Why?
|
| Community-Acquired Infections | 1 | 2005 | 94 | 0.060 |
Why?
|
| Sus scrofa | 1 | 2004 | 28 | 0.060 |
Why?
|
| Insufflation | 1 | 2004 | 9 | 0.050 |
Why?
|
| Middle Aged | 1 | 2021 | 17480 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 176 | 0.050 |
Why?
|
| Pressure | 1 | 2004 | 79 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 112 | 0.050 |
Why?
|
| Models, Animal | 1 | 2004 | 236 | 0.050 |
Why?
|
| Swine | 1 | 2004 | 370 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 25 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 433 | 0.050 |
Why?
|
| Gangrene | 1 | 2020 | 7 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 111 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1372 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 108 | 0.030 |
Why?
|
| Plant Roots | 1 | 2015 | 63 | 0.030 |
Why?
|
| Risk Factors | 1 | 2005 | 5331 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 207 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 607 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 934 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 892 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 862 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1274 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 504 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2014 | 360 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1645 | 0.020 |
Why?
|
| Bacteriuria | 1 | 2007 | 16 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2006 | 25 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2007 | 87 | 0.020 |
Why?
|
| Sheep | 1 | 2006 | 179 | 0.020 |
Why?
|
| Testis | 1 | 2006 | 144 | 0.020 |
Why?
|
| Recurrence | 1 | 2007 | 639 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 315 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 204 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 784 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2007 | 3270 | 0.010 |
Why?
|